The Independent |
If we want to avoid another Martin Shkreli or an EpiPen pricing fiasco, this is how we need to deal with …
The Independent Many will say that responsibility lies with the greedy bosses of these companies. Since an outfit called Mylan acquired the “EpiPen” in 2007 the price of the emergency allergy treatment has risen almost five fold. Over that period Mylan’s boss, Heather … |
…

